Cite
Vellas B, Bateman R, Blennow K, et al. Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015;2(2):128-135doi: 10.14283/jpad.2015.55.
Vellas, B., Bateman, R., Blennow, K., Frisoni, G., Johnson, K., Katz, R., Langbaum, J., Marson, D., Sperling, R., Wessels, A., Salloway, S., Doody, R., Aisen, P. (2015). Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force. The journal of prevention of Alzheimer's disease, 2(2), 128-135. https://doi.org/10.14283/jpad.2015.55
Vellas, B, et al. "Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force." The journal of prevention of Alzheimer's disease vol. 2,2 (2015): 128-135. doi: https://doi.org/10.14283/jpad.2015.55
Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, Langbaum J, Marson D, Sperling R, Wessels A, Salloway S, Doody R, Aisen P. Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015 Jun;2(2):128-135. doi: 10.14283/jpad.2015.55. PMID: 26247004; PMCID: PMC4523051.
Copy
Download .nbib